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The final stage of in vitro osteogenic differentiation is characterized by the production of mineral deposits
containing calcium cations and inorganic phosphates, which populate the extracellular matrix (ECM) surrounding
the cell monolayer. Conventional histological techniques for the assessment of mineralization, such as Von Kossa
and Alizarin Red S staining, are end point techniques requiring cell fixation. Moreover, in both cases staining
quantitation requires dye extraction, which irreversibly alters the ECM conformation and structure, therefore
preventing the use of the sample for further analysis. In this study, the use of tetracycline hydrochloride (TC) is
proposed for the nondestructive staining, quantitation, and imaging of mineralizing bone-like nodules in live
cultures of human bone marrow mesenchymal stem cells cultured under osteogenic conditions. Overnight ad-
ministration of TC to living cells was shown not to alter the metabolic activity or the progression of cell differ-
entiation. When applied to differentiating cultures, cell exposure to serial doses of TC was found to produce
quantifiable fluorescence emission specifically in osteogenic cultures. Incubation with TC enabled fluorescence
imaging ofmineralized areas in live cultures and the combinationwith other fluorophores using appropriate filters.
These results demonstrate that serial TC administration over the differentiation time course provides a qualitative
and quantitative tool for the monitoring and evaluation of the differentiation process in live cells.
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Introduction
The cellular process underpinning bone formation isroutinely modeled in vitro using different types of cells,
including primary osteoblasts and multipotent and pluripotent
stem cells which, under specific physicochemical stimulation,
differentiate into mineralizing bone-like cells.1 During osteo-
genic differentiation, a well-organized and collagen-enriched
extracellular matrix (ECM) is formed followed by the pro-
duction of extracellular mineral deposits made of calcium and
inorganic phosphates.2
In conventional 2D culture systems, these mineral de-
posits can be identified on top of the cell monolayer through
brightfield imaging.3 However, qualitative and quantitative
assessments of mineralization are essential for the full charac-
terization of differentiation and are conventionally achieved
with histological stain techniques. The most widely used assays
include Von Kossa and Alizarin Red S staining, which re-
spectively target anionic phosphates and calcium cations.4,5
However, both methods are end point assays and require
cell fixation, followed by multiple staining steps. To over-
come these limitations and enable live analyses, diverse
fluorochrome-based labeling methods have been proposed for
the evaluation of bone formation in vitro and in vivo such as
Giemsa, Calcein blue, and Xylenol Orange, among others.6–9
Tetracyclines (TCs) constitute a wide family of broad
spectrum antibiotics classified as natural, semisynthetic, and
chemically modified according to their origin.10 In addition to
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their antimicrobial activity, these compounds are character-
ized by their calcium chelating ability and fluorescence emis-
sion.11,12 These properties have led TCs to be used as a
marker of calcification front in bone, applied in vivo by
parenteral or enteral administration or used for staining bone
biopsies postfixation.13 TCs have also more recently been
used for the qualitative observation of mineralized ECM in
dental pulp cell culture by fluorescence imaging.14 How-
ever, TCs have not yet been used for the quantitative eval-
uation of mineralization in live cultures.
The aim of this study was to investigate the use of tetracy-
cline hydrochloride for the nondestructive in vitro staining,
quantification, and live imaging of bone-like mineralized ECM
using differentiating human mesenchymal stem cells (MSCs).
Materials and Methods
All reagents were purchased from ThermoFisher Scien-
tific (UK) unless otherwise stated.
Cell culture and differentiation
Immortalized human bone marrow-derived MSCs15–18
were seeded at a density of 4000 cells/cm2 in 48-well plates.
After 24 h, the standard medium (SC) (low-glucose Dulbecco’s
modified Eagle’s medium supplemented with 10% fetal calf
serum, 1% penicillin and streptomycin, 1% L-Glutamine,
and 1% of nonessential amino acids) was replaced with
osteogenic medium (OS) (SC supplemented with 0.1 mM
dexamethasone, 10mM b-glycerophosphate, and 50 mM
ascorbic acid; Sigma-Aldrich, UK) to induce osteogenic
lineage differentiation.19 Cells were cultured for 21 days at
37C and 5% CO2, with medium refreshment every 48 h.
Evaluation of cytotoxicity
Cell metabolic activity was analyzed using PrestoBlue
reagent at days 7, 14, and 21, according to the manufac-
turer’s instructions. Briefly, the cells were washed once with
phosphate buffered saline (PBS) and incubated with 300mL
of SC containing 10% of PrestoBlue reagent at 37C for
40min which was within the dynamic range of the assay.
Two hundred fifty microliters were transferred to a new 96-
well plate, and the fluorescence was measured in a micro-
plate reader (Tecan Infinite 200) using excitation and
emission wavelengths set at 560 and 590 nm, respectively.
Alkaline phosphatase assay and Alizarin
Red S staining
Alkaline phosphatase (ALP) activity was assayed at days
7 and 14 of culture. A solution containing 1mg/mL
p-nitrophenyl phosphate and 0.2M Tris buffer (SIGMA-
FAST; Sigma-Aldrich) was prepared according to the
manufacturer’s instructions. Cells seeded in 48-well plates
were washed twice with PBS, and 300mL of assay solution
was added to each well. ALP activity was monitored by
performing 12 readings of the optical density at 405 nm over
24min in a microplate reader. Cells were then washed twice,
and fresh medium was added before returning the cells to
the incubator until the following time point.
Alizarin Red S staining was performed at days 7, 14, or 21
as stated. Cell fixation was performed using 4% parafor-
maldehyde for 10min at 4C. Before the staining, fixed cells
were washed twice with deionized water. Then, 200mL of 1%
w/v Alizarin Red S solution (Sigma-Aldrich) was added to
each well for 10–15min, followed by extensive washing with
deionized water before imaging. For Alizarin Red S staining
quantification, stained cells were washed with deionized
water and incubated with 200mL of destaining solution (20%
methanol, 10% acetic acid in deionized water) during
15–20min before measuring the absorbance of the solution at
405 nm in the microplate reader.
Tetracycline administration and analysis
of fluorescence emission
The tetracycline staining solution chosen was prepared with
tetracycline hydrochloride (TC) (Sigma-Aldrich) dissolved in
PBS, filtered through 0.22 mm syringe filter, and adminis-
trated to the cells at final concentrations of 5, 10, 20, or
40 mg/mL in culture medium at days 6, 13, and 20. After
overnight incubation (18–22 h) with TC, cells were washed
twice with PBS; then, 300mL of PBS was added to each
well, and fluorescence was measured using the microplate
reader (Tecan Infinite 200), recording 25 reading points per
well at 390 nm excitation and 560 nm emission.
Cell staining and imaging
For both live and fixed samples, cell nuclei were coun-
terstained by incubating cells with 10mg/mL of Hoechst
33258 for 10min. Cytoskeletal actin fibers were visualized in
fixed cells using VECTASHIELD mounting medium con-
taining TRITC-Phalloidin (Vector Laboratories, UK).
Live cells were imaged on a Leica DM IRB microscope
using the A filter cube (excitation filter l 340–380 nm,
emission long pass filter l 425 nm) and coupled to a QI-
CAM Fast 1394 camera. Confocal laser scanning micros-
copy was carried out on a ZEISS Elyra PS.1 microscope
equipped with LSM 780 confocal unit using 10 · /0.45NA
water immersion objective. The TC emission spectrum was
acquired in Lambda mode using a 32-channel meta-detector
in the confocal microscope. After inspecting the emission
signals, sequential imaging channels were set for each
fluorophore, and for each channel the respective laser was
assigned: Hoechst: lex. 405 nm laser, lem. 405–437 nm; TC:
lex. 405 nm laser, lem. 588–650 nm; and TRITC-Phalloidin:
lex. 561 nm laser, lem. 579–641 nm.
Statistics
Results from three independent experiments are presented
as mean – standard error of the mean. One-way analysis of
variance with Tukey’s multiple comparison post hoc test
was used. A 95% confidence level was considered signifi-
cant. Statistical analysis was performed with the GraphPad
PRISM 7.01 software package.
Results
Tetracycline as an in vitro live stain
for osteogenic differentiation
To test the ability of TC to stain mineralizing cells in
culture and determine the optimal working concentra-
tion, differentiated and undifferentiated MSCs cultured for
20 days in vitro were incubated for 18–22 h with four TC
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concentrations. Live fluorescence imaging revealed a green
staining pattern that colocalized with the grainy mineral
deposits visible on the top of the cell monolayer in bright-
field mode. The signal was stronger and more defined as the
TC concentration increased, while no staining was detected
in either differentiated cells unexposed to TC or in undif-
ferentiated cells treated with 40mg/mL of TC (Fig. 1A).
Alizarin Red S staining performed at day 21 in postfixed
cells confirmed the differentiated phenotype of cells tran-
siently exposed to the four concentrations of TC and showed
no significant differences between all treatment groups
( p = 0.47), confirming that TC exposure did not interfere
with the staining (Fig. 1A, B). Semiquantitation of DNA
amount (Supplementary Fig. S1; Supplementary Data are
available online at www.liebertpub.com/tec) and analysis of
metabolic activity (Fig. 1C) performed in cells treated with
increasing TC concentrations also showed no differences
( p = 0.77) among the different groups, confirming that the
TC treatment was nontoxic at all concentrations tested in
this study.
The fluorescence intensity observed in TC-treated cultures
was measured using a microplate reader, and TC signal was
significantly higher in cells treated with osteogenic condition
than in undifferentiated cells maintained in SC medium
(Fig. 2). The 40mg/mL concentration resulted in significantly
higher values in comparison to all the other concentrations in
both culture conditions (Fig. 2).
Tetracycline fluorescence spectrum and co-staining
with other fluorescent dyes
To define the optimal imaging settings for TC cell label-
ling, the lambda mode of the confocal microscope was used
with 405, 488, 561, or 633 nm lasers to detect the whole TC
spectra in fixed cells treated with 20mg/mL of TC. Strong
emission was detected when a 405 nm laser was used with
two major peaks at 520 and 584 nm. Importantly, relatively
low signals (<8%) were observed in the emission spectra
acquired at other wavelengths (488, 561, and 633 nm), sug-
gesting little or no signal spillover (Supplementary Fig. S2).
To test the possibility of using TC concomitantly with
other fluorescent dyes, fixed cells treated with 20mg/mL of
TC were co-stained with Hoechst 33258 and TRITC-
Phalloidin to label nuclei and cytoskeleton, respectively. No-
tably, using the 405 nm laser, a residual Hoechst 33258 signal
was detected at 520 nm but not at 584 nm. Therefore, the TC
imaging protocol was optimized using the 405nm laser with
detection in the range of 588–650 nm, providing a specific TC
signal without any spillover signal from Hoechst 33258 or
Phalloidin-TRITC fluorophores (Fig. 3).
FIG. 1. Human MSC cultures exposed to increasing doses of TC at day 20 of differentiation treatment. Scale bar: 125mm.
(A) Representative images of cells cultured in SC or OS media after TC (green) and Alizarin Red S staining. (B, C)
Quantification of Alizarin Red S staining (B) and metabolic activity (C). (n = 3). MSCs, mesenchymal stem cells; OS,
osteogenic medium; SC, standard medium; TC, tetracycline. Color images available online at www.liebertpub.com/tec
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Live Tetracycline staining in differentiating cells
To further optimize TC staining for live monitoring of
osteogenic differentiation, TC administration to live cultures
was performed in either single or serial doses (20mg/mL) at
days 6, 13, and 20 (Fig. 4A), to evaluate the biocompatibility
and efficiency of multiple TC exposures. Cells exposed to
single or repeated TC treatment were first observed under
fluorescence microscopy to evaluate the nature and distribu-
tion of the staining overtime (Fig. 4B). Live imaging revealed
visible TC-stained mineral deposits at days 14 and 21 of OS
treatment, but not at day 7, suggesting minimal differentiation
at this time point. At day 14, the TC staining pattern and signal
intensity were similar in cells exposed to single and serial TC
doses. At day 21 of differentiation however, a sharper and
more defined signal was observed after serial administration
of TC (three consecutive doses) in comparison to a single
administration, suggesting a cumulative effect of serial TC
treatment from day 14 but not from day 7.
Quantification of TC fluorescence was performed in liv-
ing cells at days 7, 14, and 21 of OS differentiation to
complement the microscopy observation, confirming time-
dependent increase in TC signal (Fig. 5A). The adminis-
tration of serial doses resulted in significantly higher TC
fluorescence intensity at day 21 in comparison to the single
dose administration protocol. Power analysis performed to
evaluate the assay’s sensitivity showed that the adminis-
tration of TC 20 mg/mL had a power of 97% and 100% to
discriminate twofold and fivefold differences with three
samples in each group, and to discriminate a 1.5-fold dif-
ference the assay’s power was of 78% with six samples.
When analyzing cellular parameters, TC exposure was not
found to negatively affect metabolic activity after either
single or serial doses at any of the time points analyzed
(Fig. 5B), and measurements of ALP activity at days 7 and 14
showed comparable levels in cells after single or serial TC
treatment and cells unexposed to TC (Fig. 5C). The Alizarin
Red S staining performed confirmed the progression of cell
differentiation from days 7 to 21 (Supplementary Fig. S3).
Importantly, staining quantification (Fig. 5D) revealed no
significant differences in mineral deposition at any time point
between untreated and TC-treated cells, whether using single
or serial doses, indicating that TC treatment did not interfere
with the progression of cellular differentiation ( p > 0.9999).
To confirm the versatility of the assay, the serial admin-
istration of 20mg/mL TC was also performed to human pri-
mary MSCs, which constitutes a clinical relevant cell type but
also to the mouse D1 immortalized MSCs which is widely
used in in vitro studies (see Supplementary Data). Live fluo-
rescence imaging showed for both cell types a sharp and de-
fined staining pattern at day 21 after three treatments with TC
(Supplementary Fig. S4).
Discussion
The use of in vitro live cell assays permits the monitoring
and evaluation of cell status in ongoing cultures, allowing
longitudinal assessment of cellular responses in real time. In
the field of bone research and tissue engineering this is
important as in vitro studies involve long-term experiments
to allow for ECM maturation and mineralization, which are
typically considered over 3 weeks of cell culture. The as-
sessment of the ALP enzymatic activity in living cells allows
for the evaluation of the status of the cell differentiation in
real time during the in vitro culture period; however, this
targets the early stage of differentiation.2 Moreover, molecular
FIG. 2. Quantification of TC fluorescence in MSCs cul-
tured during 21 days in SC (white) or OS (black) medium
containing increasing TC doses. SC, standard medium; OS,
osteogenic medium. *p < 0.05, **p < 0.01, ***p < 0.001,
****p < 0.0001.
FIG. 3. Representative images of
OS-treated cells at day 21 stained
with TC 20mg/mL (green) or only
phosphate buffered saline and
counterstained with Hoechst 33258
(blue) and Phalloidin (red). Scale
bar: 125 mm. Color images avail-
able online at www.liebertpub
.com/tec
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reporter systems engineered using osteogenic gene promoters
to drive a reporter marker can allow for a direct follow-up of
gene expression and differentiation profile20; however, these
imply genetic manipulations therefore preventing their direct
application in primary cells. To overcome these limitations,
we have developed a new protocol for the nondestructive
measurement of mineralization in live cultures using tetracy-
cline hydrochloride. We have also defined the optimal regime
of TC administration to enable staining, quantification, and
fluorescence imaging in live cells using human MSCs as a
differentiation model. We have also showed that TC staining
can be multiplexes with other fluorophores to enable advanced
cellular analysis of osteogenic cultures.
Among the several tetracycline derivatives available and
already in use for in vivo bone labeling, we selected tetracy-
cline hydrochloride as it displayed the highest brightness in
comparison to others when used to label rat bone samples.21
Our results showed that TC administrated in vitro as single or
repeated doses did not alter the metabolic activity of human
MSCs. The results of several studies suggest that different
administration protocols and/or TC derivatives may differ-
ently affect cell health and also that sensitivity to TC deriv-
atives might be cell type dependent. Indeed, MG-63 human
osteosarcoma cells experienced a decrease in number after
overnight incubation with 10mg/mL doxycycline and a sig-
nificant reduction of proliferation after daily treatment with
the same dose of the compound.22 The treatment of primary
human osteoblasts with 190mg/mL of TC resulted in a 30%
increase of lactate dehydrogenase, which was considered as an
indication of impaired mitochondrial function, and suggested
that this cytotoxic effect could be partially mediated by an
alteration of mitochondrial respiration.23 Another study re-
ported that the administration of TC analogs (doxycycline,
COL-3, and minocycline) from 10mg/mL to the acute myeloid
leukemia cell line HL60 reduced cell viability of >50%. By
contrast, 1mg/mL of doxycycline and minocycline continu-
ously added to the cell culture medium have been reported to
significantly increase the proliferation of human osteoblastic
bone marrow cells.24,25 Our results also showed that TC ad-
ministration at days 7 and 14 during the culture period did not
interfere with the induction and progression of the differenti-
ation process. For both ALP activity and mineral deposition
assays, no significant differences were observed between
cells treated with single and serial doses of TC in compar-
ison to cultures unexposed to TC. In this regard too, existing
reports on the effect of TC treatment on bone differentiation
are contradictory and might depend on the TC derivative
used, the dose, and the administration regime. In vitro, the
daily administration of 1 mg/mL of doxycycline or minocy-
cline seemed to significantly promote the mineralization of
human bone marrow-derived osteoblasts.25 In vivo, several
studies performed on diverse disease models (such as dia-
betes, osteopenia, and osteoporosis) in mice and rats re-
ported a positive association between the administration of
TC derivatives and bone formation and density.26–29 How-
ever, it has been proposed that such an effect observed
in vivo might be mediated by an inhibitory effect of TC on
osteoclast function.29,30 As an opposite trend, TC adminis-
tration at early stages of development or to ex vivo embry-
onic bones, bone growth was compromised followed by
increase in bone fragility.31,32
The present study also demonstrated that TC is a suitable
compound for the evaluation of osteogenic differentiation in
living cells such as MSCs, over an extended culture period.
All the TC doses tested in this study (5–40 mg/mL) were
selected within the same range as previously reported14,32
and were suitable for the fluorescent labeling of mineralizing
cells, resulting in a more defined signal as the concentration
increased. This trend was confirmed by spectrophotometric
analysis, which revealed a linear increase of the detected
fluorescence signal. However, among the TC doses tested in
this study, 20 mg/mL was selected as optimum to monitor
the progression of MSC differentiation at various time
points. While the highest dose (40 mg/mL) provided a more
defined and brighter signal in fluorescent images, the spec-
trophotometric quantitation also showed a significant in-
crease of the signal in undifferentiated cells, suggesting the
FIG. 4. Live fluorescence monitoring of MSC differenti-
ation using single or serial doses of TC. (A) Diagram and
timeline of TC administration to live cells under osteogenic
treatment for 7, 14, and 21 days. (B) Representative fluo-
rescence images of OS-treated live MSCs at days 7, 14, and
21 after single and serial TC exposure (20mg/mL, green)
compared to unexposed controls. Scale bar: 125mm. Color
images available online at www.liebertpub.com/tec
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increase of unspecific background signal at this concentra-
tion. In our study, TC labeling was clearly visible as green
stain using a conventional DAPI long pass filter at days 14
and 21, but not at day 7 of osteogenic treatment. This result
was in agreement with the spectrophotometric quantitation
of TC fluorescence signal and was also confirmed by par-
allel Alizarin Red S staining, which did not reveal any de-
tectable mineral deposits at day 7. Due to the calcium
tropism of TC, the presence of calcium phosphate minerals
in the ECM is necessary for the staining. The production of
mineralized ECM is a late event during bone-lineage dif-
ferentiation, starting around days 10–12, while the earlier
period is characterized by active cell proliferation and pro-
duction of ECM components.2 Serial TC administration
resulted in a stronger and more defined staining in MSC
cultures, particularly at day 21, in comparison to the single
dose administration. This result, observed by microscopy
and confirmed by spectrophotometry, suggests the retention
and accumulation of the dye into the mineralizing bone-like
nodules between the different administrations over the
21 days of culture. This appears in agreement with in vivo
studies reporting the retention and visualization of this
compound in bones up to 4 weeks after administration.33
These results confirm the suitability of TC staining to
monitor the progression of live MSC differentiation at var-
ious time points, using a simple and cell neutral protocol.
The real-time evaluation of mineralizing cultures has
previously been achieved by the continuous administration
of Calcein without affecting the cell viability or the pro-
gression of differentiation, resulting in a green labeling
visible through a FITC long pass filter.8 However, this
method is based on the uptake of Calcein by living cells;
therefore its use is limited to live cultures while the TC can
also be used in fixed samples.3,13 In this regard, it is worth
noting that TC allows for the multiplex staining with
fluorophores visible in other channels, including the nuclear
dye Hoechst 33258 and TRITC-conjugated Phalloidin as
shown in our study, and is therefore a versatile tool for
immunohistochemistry analysis. Moreover, our results show
that the quantitative assessment of mineralization at specific
time points can be achieved by an incubation of <24 h with
TC resulting in quantifiable and visible signal.
In summary, in this study we have developed a new
protocol for the quantitative monitoring and quantitation of
cell mineralization in real time based on the use of tetra-
cycline hydrochloride. In comparison to conventional his-
tological methods such as Alizarin Red S and Von Kossa
staining, which are end point assays and require multiple
steps for staining and dye quantification, the use of TC is
cytocompatible, can be performed in live cells lowering the
number of cells required for longitudinal studies, and is
both straightforward and economical. Overnight incubation
results in visible and quantifiable fluorescence signal, which
can be quantified by spectrophotometry directly from live
cultures while being compatible with the use of other
fluorophores in live and fixed samples, enabling multiplex
immunohistochemistry analysis. TC cell labeling enables
the in vitro evaluation of osteogenic differentiation in dif-
ferent cell models, including human primary stem cells, and
can thus support research into bone repair and tissue engi-
neering targeting new pro-osteogenic approaches.
Conclusions
In this study, we have described a new nondestructive
method for the live and quantitative staining of MSC cul-
tures undergoing osteogenic differentiation, based on the
transient administration of tetracycline hydrochloride during
the culture period. The results showed this method to be
nontoxic, sensitive, and quantitative. TC can be selectively
FIG. 5. Time course anal-
ysis of the single or serial TC
exposure (20mg/mL) on
MSC cultures compared to
no TC exposure. (A) TC
fluorescence signal quantita-
tion showing increased signal
upon repeated exposure.
(B–D) Cell metabolic activ-
ity (B), ALP activity (C), and
Alizarin Red S staining
quantitation (D) in MSC
cultures showing no signifi-
cant difference across all
conditions. n= 3. ALP,
alkaline phosphatase.
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imaged by fluorescent microscopy in live cells and enables
the concomitant use of other fluorophores, which offers a
useful and versatile method for high throughput analysis of
osteogenic cultures.
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